Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...

1 Day 2269 14.38% DJIA -1.30% S&P 500 -1.39% Health Care/Life Sciences 1.12% ...

To help you manage symptoms of AS, a doctor may recommend a therapy called biologics. AS primarily affects the spinal joints, but large joints, such as the hips and shoulders, can also be involved.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We've identified the following companies as similar to WuXi Biologics (Cayman) Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics ...

HCW Biologics Inc., a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for age-related diseases, announced that the Nasdaq Hearings Panel has granted it an ...

2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), and Civica, Inc. (Civica), a not-for ...

Innovent Biologics, Inc., a biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and ...

Credit: Saiful52/Shutterstock. WuXi Biologics has launched the E coli expression system, EffiX, designed to enhance the production of recombinant proteins and plasmid DNA (pDNA). The worldwide market ...

To address the challenges in producing these biomolecules, WuXi Biologics has introduced the EffiX™ platform, which enables the development and manufacturing of microbial-derived biologics with high ...